192
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Surface modified kokum butter lipid nanoparticles for the brain targeted delivery of nevirapine

&
Pages 680-694 | Received 02 Sep 2018, Accepted 21 Jan 2019, Published online: 18 Mar 2019
 

Abstract

Aim: The present work investigates the efficacy of Polysorbate 80(P80) coated Kokum butter (KB) solid lipid nanoparticles (P80NvKLNs) for the brain targeted delivery of Nevirapine (Nv).

Methods: Solid lipid nanoparticles (SLNs) were prepared by nanoprecipitation technique and evaluated for drug excipient compatibility studies, z- average particle size (nm), zeta potential (mv), percentage drug entrapment efficiency (%EE), surface morphology and in-vitro drug release properties. The in-vivo biodistribution and brain targeting efficiency of nanoparticles were studied in healthy male Wistar rat (150–200 g).

Results: P80NvKLNs were found to be smooth surfaced, spherical shaped having average particle size of 177.80 ± 0.82 nm, zeta potential of −8.91 ± 4.36 mv and %EE of 31.32 ± 0.42%. P80NvKLNs remained in blood circulation for 48 h maintaining a sustained release in brain for 24 h (p < 0.05).

Conclusion: The study proves the efficacy of Polysorbate 80 coated Kokum butter nanoparticles for brain-targeted delivery of drugs providing ample opportunities for further study.

Acknowledgement

The authors are thankful to Dibrugarh University, Girijananda Choudhury Institute of Pharmaceutical Sciences (GIPS), Indian Institute of Advances in Science and Technology (IASST), Northeast Hill University (NEHU), College of Veterinary Sciences, AAU and Guwahati Biotech Park for their support in carrying out the work.

Disclosure statement

The author has no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.